Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran

References

• Mansoori N, Douraghi M, Rajabloo AA, Taziki M, Yaseri M, Vaziri F. Mycobacterium tuberculosis complex drug resistance in a high tuberculosis incidence area from the WHO eastern mediterranean region. J Pharm Pharm Sci. 2017;20(1):428–434. doi:10.18433/J3J64H29197427
   PubMedGoogle Scholar
• WHO. Global Tuberculosis Report 2018. Geneva, Switzerland: WHO; 2018.
   Google Scholar
• http://www.who.int/tb/country/data/profiles. Accessed 620, 2020, 2019.
   Google Scholar
• http://tb-lep.behdasht.gov.ir/TBsituationinIran.aspx., 2019.
   Google Scholar
• Sakhaee F, Ghazanfari M, Ebrahimzadeh N, et al. A comparative study of phenotypic and genotypic first- and second-line drug resistance testing of Mycobacterium tuberculosis. Biologicals. 2017;49:33–38. doi:10.1016/j.biologicals.2017.07.00328716625
   PubMed Web of Science ®Google Scholar
• WHO. WHO Treatment Guidelines for Drug-Resistant Tuberculosis 2016 Update; 2016.
   Google Scholar
• Wayne LG. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis. 1974;109(1):147–151. doi:10.1164/arrd.1974.109.1.1474203284
   PubMed Web of Science ®Google Scholar
• Chawla K, Kumar A, Shenoy VP, Chauhan DS, Sharma P. Genetic diversity of Mycobacterium tuberculosis in south coastal Karnataka, India, using spoligotyping. Indian J Med Res. 2018;147(3):278–286. doi:10.4103/ijmr.IJMR_2026_1629923517
   PubMed Web of Science ®Google Scholar
• Monteserin J, Paul R, Gravina E, et al. Genotypic diversity of Mycobacterium tuberculosis in Buenos Aires, Argentina. Infect Genet Evol. 2018;62:1–7. doi:10.1016/j.meegid.2018.04.00629630937
   PubMed Web of Science ®Google Scholar
• Jagielski T, Minias A, van Ingen J, et al. Methodological and clinical aspects of the molecular epidemiology of Mycobacterium tuberculosis and Other Mycobacteria. Clin Microbiol Rev. 2016;29(2):239–290. doi:10.1128/CMR.00055-1526912567
   PubMed Web of Science ®Google Scholar
• Mansoori N, Yaseri M, Vaziri F, Douraghi M. Genetic diversity of Mycobacterium tuberculosis complex isolates circulating in an area with high tuberculosis incidence: using 24-locus MIRU-VNTR method. Tuberculosis. 2018;112:89–97. doi:10.1016/j.tube.2018.08.00330205974
   PubMed Web of Science ®Google Scholar
• Rieder HL, Chonde TM, Myking H, et al. The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network; Minimum Requirements, Role and Operation in a Low-Income Country. Paris: International Union against Tuberculosis and Lung Disease (IUATLD); 1998:110 p.
   Google Scholar
• WHO. Updated interim critical concentrations for first-line and second-line DST Geneva, Switzerland 2012 Available from: http://www.stoptb.org/wg/gli/assets/documents/Updated%20critical% 20concentration%20table_1st% 20and%202nd% 20line%20drugs.pdf..
   Google Scholar
• Stottmeier KD, Beam RE, Kubica GP. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Am Rev Respir Dis. 1967;96(5):1072–1075. doi:10.1164/arrd.1967.96.5.10724964643
   PubMed Web of Science ®Google Scholar
• Aono A, Hirano K, Hamasaki S, Abe C. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test. Diagn Microbiol Infect Dis. 2002;44(4):347–352. doi:10.1016/S0732-8893(02)00471-612543539
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Morlock GP, Sikes RD, et al. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011;55(5):2032–2041. doi:10.1128/AAC.01550-1021300839
   PubMed Web of Science ®Google Scholar
• van Soolingen D, De Haas PE, Hermans PW, van Embden JD. DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol. 1994;235:196–205.8057895
   PubMed Web of Science ®Google Scholar
• Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907–914. doi:10.1128/JCM.35.4.907-914.19979157152
   PubMed Web of Science ®Google Scholar
• Demay C, Liens B, Burguiere T, et al. SITVITWEB–a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol. 2012;12(4):755–766. doi:10.1016/j.meegid.2012.02.00422365971
   PubMed Web of Science ®Google Scholar
• Haeili M, Darban-Sarokhalil D, Fooladi AA, et al. Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis isolates from five provinces of Iran. Microbiologyopen. 2013;2(6):988–996. doi:10.1002/mbo3.13924311556
   PubMed Web of Science ®Google Scholar
• Sharma P, Chauhan DS, Upadhyay P, et al. Molecular typing of Mycobacterium tuberculosis isolates from a rural area of Kanpur by spoligotyping and mycobacterial interspersed repetitive units (MIRUs) typing. Infect Genet Evol. 2008;8(5):621–626. doi:10.1016/j.meegid.2008.05.00218567544
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Mistry N. MIRU-VNTR profiles of three major Mycobacterium tuberculosis spoligotypes found in western India. Tuberculosis. 2013;93(2):250–256. doi:10.1016/j.tube.2012.10.00423219234
   PubMed Web of Science ®Google Scholar
• Arora J, Singh UB, Suresh N, et al. Characterization of predominant Mycobacterium tuberculosis strains from different subpopulations of India. Infect Genet Evol. 2009;9(5):832–839. doi:10.1016/j.meegid.2009.05.00819463970
   PubMed Web of Science ®Google Scholar
• Ali A, Hasan Z, Jafri S, Inayat R, Hasan R. Mycobacterium tuberculosis Central Asian Strain (CAS) lineage strains in Pakistan reveal lower diversity of MIRU loci than other strains. Int J Mycobacteriol. 2014;3(2):108–116. doi:10.1016/j.ijmyco.2014.03.00226786332
   PubMedGoogle Scholar
• Al-Hajoj S, Varghese B, Al-Habobe F, Shoukri MM, Mulder A, van Soolingen D. Current trends of Mycobacterium tuberculosis molecular epidemiology in Saudi Arabia and associated demographical factors. Infection, Genetics and Evolution. 2013;16:362–368. doi:10.1016/j.meegid.2013.03.019
   PubMed Web of Science ®Google Scholar
• Allix-Beguec C, Harmsen D, Weniger T, Supply P, Niemann S. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2008;46(8):2692–2699. doi:10.1128/JCM.00540-0818550737
   PubMed Web of Science ®Google Scholar
• Ravansalar H, Tadayon K, Mosavari N, Derakhshan M, Ghazvini K. Genetic Diversity of Mycobacterium tuberculosis Complex Isolated from Patients in the Northeast of Iran by MIRU-VNTR and Spoligotyping. Jundishapur J Microbiol. 2017;10(4):e39568.
   Web of Science ®Google Scholar
• Feyisa SG, Haeili M, Zahednamazi F, et al. Molecular characterization of Mycobacterium tuberculosis isolates from Tehran, Iran by restriction fragment length polymorphism analysis and spoligotyping. Rev Soc Bras Med Trop. 2016;49(2):204–210. doi:10.1590/0037-8682-0405-201527192590
   PubMed Web of Science ®Google Scholar
• Skiba Y, Mokrousov I, Ismagulova G, et al. Molecular snapshot of Mycobacterium tuberculosis population in Kazakhstan: a country-wide study. Tuberculosis. 2015;95(5):538–546. doi:10.1016/j.tube.2015.04.01226076582
   PubMed Web of Science ®Google Scholar
• Mokrousov I, Isakova J, Valcheva V, Aldashev A, Rastogi N. Molecular snapshot of Mycobacterium tuberculosis population structure and drug-resistance in Kyrgyzstan. Tuberculosis. 2013;93(5):501–507. doi:10.1016/j.tube.2013.05.00823890973
   PubMed Web of Science ®Google Scholar
• Mokrousov I, Shitikov E, Skiba Y, Kolchenko S, Chernyaeva E, Vyazovaya A. Emerging peak on the phylogeographic landscape of Mycobacterium tuberculosis in West Asia: definitely smoke, likely fire. Mol Phylogenet Evol. 2017;116:202–212. doi:10.1016/j.ympev.2017.09.00228893611
   PubMed Web of Science ®Google Scholar
• Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang YW. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J Clin Microbiol. 2010;48(10):3544–3550. doi:10.1128/JCM.00715-1020702677
   PubMed Web of Science ®Google Scholar
• Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–1843. doi:10.1016/S0140-6736(10)60410-220488523
   PubMed Web of Science ®Google Scholar
• Merker M, Blin C, Mona S, et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet. 2015;47(3):242–249. doi:10.1038/ng.319525599400
   PubMed Web of Science ®Google Scholar
• Balabanova Y, Nikolayevskyy V, Ignatyeva O, et al. Beijing clades of Mycobacterium tuberculosis are associated with differential survival in HIV-negative Russian patients. Infect Genet Evol. 2015;36:517–523. doi:10.1016/j.meegid.2015.08.02826319998
   PubMed Web of Science ®Google Scholar
• Zamani S, Haeili M, Nasiri MJ, Imani Fooladi AA, Javadpour S, Feizabadi MM. Genotyping of Mycobacterium tuberculosis Isolates from Hormozgan Province of Iran Based on 15-Locus MIRU-VNTR and Spoligotyping. Int J Bacteriol. 2016;2016:7146470. doi:10.1155/2016/714647027819023
   PubMedGoogle Scholar
• Torkaman MR, Nasiri MJ, Farnia P, Shahhosseiny MH, Mozafari M, Velayati AA. Estimation of recent transmission of mycobacterium tuberculosis strains among iranian and afghan immigrants: a cluster-based study. J Clin Diagn Res. 2014;8(9):5–8.
   Google Scholar
• Sharifipour E, Nasiri M, Farnia P, Mozafari M, Irani S. Evaluation of molecular diversity of Mycobacterium tuberculosis strains by polymorphisms in RD Regions. J Mycobac Dis. 2014;4(153):2161.
   Google Scholar
• Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect. 2007;13(6):620–626. doi:10.1111/j.1469-0691.2007.01711.x17403134
   PubMed Web of Science ®Google Scholar
• Hazbon MH, Brimacombe M, Bobadilla Del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2006;50(8):2640–2649. doi:10.1128/AAC.00112-0616870753
   PubMed Web of Science ®Google Scholar
• Doustdar F, Khosravi AD, Farnia P, Masjedi MR, Velayati AA. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. Microbial Drug Resist. 2008;14(4):273–279. doi:10.1089/mdr.2008.0842
   Web of Science ®Google Scholar
• Bostanabad SZ, Nojoumi SA, Jabbarzadeh E, et al. High level isoniazid resistance correlates with multiple mutation in the katG encoding catalase proxidase of pulmonary tuberculosis isolates from the frontier localities of Iran. Tuberk Toraks. 2011;59(1):27–35. doi:10.5578/tt.76121554227
   PubMedGoogle Scholar
• Yasmin M, Gomgnimbou MK, Siddiqui RT, Refregier G, Sola C. Multi-drug resistant Mycobacterium tuberculosis complex genetic diversity and clues on recent transmission in Punjab, Pakistan. Infect Genet Evol. 2014;27:6–14. doi:10.1016/j.meegid.2014.06.01724981519
   PubMed Web of Science ®Google Scholar
• Abbadi SH, Sameaa GA, Morlock G, Cooksey RC. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. Int J Infect Dis. 2009;13(6):673–678. doi:10.1016/j.ijid.2008.10.00619138546
   PubMed Web of Science ®Google Scholar
• van Deun A, Aung KJ, Bola V, et al. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol. 2013;51(8):2633–2640. doi:10.1128/JCM.00553-1323761144
   PubMed Web of Science ®Google Scholar
• Suresh N, Singh UB, Arora J, et al. rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India. Infect Genet Evol. 2006;6(6):474–483. doi:10.1016/j.meegid.2006.03.00116621726
   PubMed Web of Science ®Google Scholar
• Velayati AA, Masjedi MR, Farnia P, et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest. 2009;136(2):420–425. doi:10.1378/chest.08-242719349380
   PubMed Web of Science ®Google Scholar
• Tasbiti AH, Yari S, Ghanei M, Shokrgozar MA, Fateh A, Bahrmand A. Low levels of extensively drug-resistant tuberculosis among multidrug resistant tuberculosis isolates and their relationship to risk factors: surveillance in Tehran, Iran; 2006 to 2014. Osong Public Health Res Perspect. 2017;8(2):116–123. doi:10.24171/j.phrp.2017.8.2.0328540155
   PubMedGoogle Scholar
• Masjedi MR, Farnia P, Sorooch S, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis. 2006;43(7):841–847. doi:10.1086/50754216941364
   PubMed Web of Science ®Google Scholar
• Chang KC, Yew WW, Zhang Y. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother. 2011;55(10):4499–4505. doi:10.1128/AAC.00630-1121768515
   PubMed Web of Science ®Google Scholar
• Mitchison DA. The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 1985;66(3):219–225. doi:10.1016/0041-3879(85)90040-63931319
   PubMedGoogle Scholar
• Doustdar F, Khosravi AD, Farnia P. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran. Microbial Drug Resist. 2009;15(4):251–256. doi:10.1089/mdr.2009.0066
   Web of Science ®Google Scholar